Holdings (as at 2025-09-17)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Insmed Incorporated 3.06%
United Therapeutics Corporation 2.99%
Tempus AI, Inc. (Class A) 2.89%
Elanco Animal Health Incorporated 2.74%
Jazz Pharmaceuticals Plc 2.60%
Biogen Inc. 2.45%
Regeneron Pharmaceuticals, Inc. 2.37%
Alnylam Pharmaceuticals, Inc. 2.36%
Zimmer Biomet Holdings, Inc. 2.33%
Universal Health Services, Inc. (Class B) 2.20%
Merck & Co., Inc. 2.18%
Acadia Healthcare Company, Inc. 2.05%
Johnson & Johnson 1.98%
Avantor, Inc. 1.96%
Exelixis, Inc. 1.95%
Cardinal Health, Inc. 1.88%
UnitedHealth Group Incorporated 1.87%
Humana Inc. 1.87%
Organon & Co. 1.84%
HCA Healthcare, Inc. 1.77%
Natera, Inc. 1.77%
Insulet Corporation 1.74%
Pfizer Inc. 1.69%
Abbott Laboratories 1.68%
BioMarin Pharmaceutical Inc. 1.68%
Veeva Systems Inc. (Class A) 1.62%
Incyte Corporation 1.59%
Boston Scientific Corporation 1.56%
The Cigna Group 1.53%
IDEXX Laboratories, Inc. 1.52%
Doximity, Inc. (Class A) 1.51%
Medtronic Plc 1.38%
Teleflex Incorporated 1.35%
Elevance Health Inc. 1.35%
ResMed Inc. 1.34%
Tenet Healthcare Corporation 1.33%
GE HealthCare Technologies Inc. 1.32%
Corcept Therapeutics Inc. 1.31%
Quest Diagnostics Incorporated 1.30%
Gilead Sciences, Inc. 1.29%
Bristol-Myers Squibb Company 1.27%
Exact Sciences Corporation 1.26%
Royalty Pharma Plc (Class A) 1.26%
Centene Corporation 1.25%
IQVIA Holdings Inc. 1.01%
Thermo Fisher Scientific Inc. 0.99%
Becton, Dickinson and Company 0.93%
Labcorp Holdings Inc. 0.90%
Hologic, Inc. 0.89%
Encompass Health Corporation 0.86%
Penumbra, Inc. 0.85%
Stryker Corporation 0.81%
Globus Medical, Inc. (Class A) 0.81%
Chemed Corporation 0.80%
Henry Schein, Inc. 0.78%
The Cooper Companies, Inc. 0.77%
Molina Healthcare, Inc. 0.76%
Revvity, Inc. 0.75%
Masimo Corporation 0.71%
Intuitive Surgical, Inc. 0.68%
Halozyme Therapeutics, Inc. 0.58%
West Pharmaceutical Services, Inc. 0.47%
Neurocrine Biosciences, Inc. 0.45%
Agilent Technologies, Inc. 0.43%
Steris Plc 0.41%
Danaher Corporation 0.39%
Amgen Inc. 0.39%
Solventum Corporation 0.39%
Edwards Lifesciences Corporation 0.38%
Zoetis Inc. 0.38%
DaVita Inc. 0.36%
Waters Corporation 0.35%
DexCom, Inc. 0.35%
Summit Therapeutics Inc. 0.34%
Perrigo Company Plc 0.32%
Align Technology, Inc. 0.27%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.